KD Pharma Group to acquire dsm-firmenich’s marine lipids business in exchange for a minority stake in the company
The transaction expands KD Pharma Group‘s lipids CDMO business and includes the MEG-3® fish oil omega-3 product portfolio and two ...
Read more
